Case Study: Global Biopharmaceutical Company achieves 60% email open rates with Veeva Systems' CRM Approved Email

Global biopharmaceutical company achieves 60% email open rates

A global biopharmaceutical company needed to expand its reps' ability to reach HCPs through preferred channels ahead of two blockbuster drug launches, while ensuring compliant digital engagement across brand, medical, and sales teams.

By deploying Veeva CRM Approved Email for 300 reps across the US, Europe, and Australia, the company achieved stronger compliance with a 1-day turnaround for approved templates, drove 30% more customer interactions, and earned 60% email open rates — three times the industry average.